Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Net Cash Flow: 2010-2025

Historic Net Cash Flow for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to -$770,559.

  • Sunshine Biopharma's Net Cash Flow fell 950.21% to -$770,559 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 64.57%. This contributed to the annual value of -$5.6 million for FY2024, which is 7.38% up from last year.
  • Per Sunshine Biopharma's latest filing, its Net Cash Flow stood at -$770,559 for Q3 2025, which was down 141.76% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Net Cash Flow ranged from a high of $28.5 million in Q2 2022 and a low of -$19.0 million during Q4 2022.
  • Its 3-year average for Net Cash Flow is -$1.1 million, with a median of -$770,559 in 2025.
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 41,959.55% in 2022, then crashed by 25,270.25% in 2024.
  • Sunshine Biopharma's Net Cash Flow (Quarterly) stood at -$335,777 in 2021, then crashed by 5,547.28% to -$19.0 million in 2022, then surged by 84.23% to -$3.0 million in 2023, then spiked by 36.95% to -$1.9 million in 2024, then tumbled by 950.21% to -$770,559 in 2025.
  • Its Net Cash Flow was -$770,559 in Q3 2025, compared to $1.8 million in Q2 2025 and -$1.6 million in Q1 2025.